Cargando…
SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Coronavirus 19 Disease (COVID-19) originating in the province of Wuhan, China in 2019, is caused by the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), whose infection in humans causes mild or severe clinical manifestations that mainly affect the respiratory system. So far, the CO...
Autores principales: | Martínez-Flores, Daniel, Zepeda-Cervantes, Jesús, Cruz-Reséndiz, Adolfo, Aguirre-Sampieri, Sergio, Sampieri, Alicia, Vaca, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311925/ https://www.ncbi.nlm.nih.gov/pubmed/34322129 http://dx.doi.org/10.3389/fimmu.2021.701501 |
Ejemplares similares
-
A self-aggregating peptide: implications for the development of thermostable vaccine candidates
por: Cruz-Reséndiz, Adolfo, et al.
Publicado: (2020) -
An ambient-temperature stable nanoparticle-based vaccine for nasal application that confers long-lasting immunogenicity to carried antigens
por: Cruz-Resendiz, Adolfo, et al.
Publicado: (2022) -
Identification of fragments from Autographa Californica polyhedrin protein essential for self-aggregation and exogenous protein incorporation
por: Sampieri, Alicia, et al.
Publicado: (2015) -
Baculovirus Display of Peptides and Proteins for Medical Applications
por: Rodríguez-Hernández, Aaron Pavel, et al.
Publicado: (2023) -
The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens
por: Duan, Liangwei, et al.
Publicado: (2020)